Butylhydroxybutylnitrosamine
"Butylhydroxybutylnitrosamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A substituted carcinogenic nitrosamine.
| Descriptor ID |
D002085
|
| MeSH Number(s) |
D02.654.442.100
|
| Concept/Terms |
Butylhydroxybutylnitrosamine- Butylhydroxybutylnitrosamine
- N-Nitrosobutyl-4-hydroxybutylamine
- N Nitrosobutyl 4 hydroxybutylamine
- N-Nitroso-N-butyl-(4-hydroxybutyl)amine
- Butylbutanolnitrosamine
- N-Butyl-N-(4-hydroxybutyl)nitrosamine
|
Below are MeSH descriptors whose meaning is more general than "Butylhydroxybutylnitrosamine".
Below are MeSH descriptors whose meaning is more specific than "Butylhydroxybutylnitrosamine".
This graph shows the total number of publications written about "Butylhydroxybutylnitrosamine" by people in this website by year, and whether "Butylhydroxybutylnitrosamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Butylhydroxybutylnitrosamine" by people in Profiles.
-
RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulation. Oncotarget. 2016 Oct 25; 7(43):69159-69172.
-
Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer. Cancer Res. 2012 Jul 01; 72(13):3135-42.
-
Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder. Carcinogenesis. 1996 Jul; 17(7):1435-8.